Adage Capital Partners Gp, L.L.C. Roivant Sciences Ltd. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51 Billion
- Q1 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 3,934,752 shares of ROIV stock, worth $41.6 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,934,752
Previous 5,275,000
25.41%
Holding current value
$41.6 Million
Previous $59.2 Million
29.99%
% of portfolio
0.08%
Previous 0.13%
Shares
8 transactions
Others Institutions Holding ROIV
# of Institutions
263Shares Held
489MCall Options Held
565KPut Options Held
1.68M-
Sb Investment Advisers (Uk) LTD London, X073MShares$771 Million7.6% of portfolio
-
Viking Global Investors LP69.4MShares$733 Million2.78% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$705 Million65.04% of portfolio
-
Black Rock Inc. New York, NY36.2MShares$382 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.6MShares$376 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.44B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...